首页> 外文会议>International Joint Conference on Neural Networks >Application of artificial neural network and multiple linear regression models for predicting survival time of patients with non-small cell cancer using multiple prognostic factors including FDG-PET measurements
【24h】

Application of artificial neural network and multiple linear regression models for predicting survival time of patients with non-small cell cancer using multiple prognostic factors including FDG-PET measurements

机译:人工神经网络和多元线性回归模型在包括FDG-PET测量在内的多种预后因素预测非小细胞癌患者生存时间中的应用

获取原文

摘要

We hypothesize and demonstrate that artificial neural networks (ANN) can perform better than multiple linear regression models in overcoming the limitations of the current TNM staging system for predicting the overall survival time of patients with non-small cell lung cancer (NSCLC). Better prognostication of survival was achieved by including additional prognostic factors, such as FDG-PET measurements and other clinical and pathological prognostic factors. The use of an ANN resulted in a substantial improvement in correlation between actual and predicted months of survival in 328 patients with NSCLC. The ANN resulted in an increase in R2, from 0.66 to 0.774, and a reduction in standard deviation, from 17.4 months to 14 months, when compared to multiple linear regressions. Furthermore, the cross-validation results of R2=0.608 suggests that the ANN model was capable of predicting survival for patients who were not included in the database for building the ANN model.
机译:我们假设并证明,人工神经网络(ANN)在克服当前TNM分期系统在预测非小细胞肺癌(NSCLC)患者总体生存时间方面的局限性方面,可以比多元线性回归模型更好。通过包括其他预后因素,例如FDG-PET测量以及其他临床和病理预后因素,可以实现更好的生存期预后。使用ANN可使328例NSCLC患者的实际生存期和预测生存期之间的相关性大大提高。与多重线性回归相比,ANN使R2从0.66增至0.774,标准偏差从17.4个月降低至14个月。此外,R2 = 0.608的交叉验证结果表明,ANN模型能够预测未包含在用于构建ANN模型的数据库中的患者的生存期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号